Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Unresectable or Metastatic Solid Malignancy × pertuzumab × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Multiple Myeloma 3 Neoplasms 2 Lymphoma, Non-Hodgkin 2 HER2-positive Breast Cancer 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Salivary Gland Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Malignant Solid Neoplasm 1 Lymphoma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Anatomic Stage II Breast Cancer AJCC v8 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡